Laura E Niklason insider trades

Open-market stock purchases and sales by Laura E Niklason, President, CEO and Director at Humacyte, Inc, from SEC Form 4 filings since Aug 26, 2021.

Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -73%.

Recent trades

DateStockTradeValue
Jun 11, 2026HUMA Humacyte, IncBought (not open market)—
Nov 16, 2025HUMA Humacyte, IncBought (not open market)—

Companies traded

  • HUMA Humacyte, Inc: 8 buys, 34 sales, last Jun 11, 2026

Get free alerts when Laura E Niklason files a new trade →